We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+2.52%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$7.16B
AUM Growth
+$666M
(+10%)
Cap. Flow
+$831M
Cap. Flow
% of AUM
11.61%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
983
New
189
Increased
207
Reduced
145
Closed
240
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$146M |
| 2 |
Gilead Sciences
GILD
|
+$116M |
| 3 |
Amazon
AMZN
|
+$86.4M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$84.7M |
| 5 |
Analog Devices
ADI
|
+$80M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$73.2M |
| 2 |
Palo Alto Networks
PANW
|
+$59.8M |
| 3 |
Alkermes
ALKS
|
+$55.3M |
| 4 |
Accenture
ACN
|
+$53.8M |
| 5 |
Johnson & Johnson
JNJ
|
+$53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.05% |
| 2 | Technology | 29.2% |
| 3 | Financials | 8.76% |
| 4 | Industrials | 7.7% |
| 5 | Communication Services | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALTR
601
DELISTED
Altair Engineering Inc
ALTR
| $434K | 0.01% |
9,809
-4,503
| -31% | -$236K |
|
|
VERO
602
DELISTED
Venus Concept
VERO
| $428K | 0.01% |
5,900
| – | – |
|
603
Gartner
IT
$11.7B
| $426K | 0.01% |
1,540
-949
| -38% | -$266K |
|
604
Sutro Biopharma
STRO
$400M
| $410K | 0.01% |
7,395
| – | – |
|
605
Braze
BRZE
$2.9B
| $396K | 0.01% |
+11,359
| New | +$480K |
|
606
Fabrinet
FN
$19.5B
| $392K | 0.01% |
4,106
+952
| +30% | +$91.6K |
|
|
CLLS
607
Cellectis
CLLS
$271M
| $389K | 0.01% |
+169,802
| New | +$514K |
|
|
CMCA
608
DELISTED
Capitalworks Emerging Markets Acquisition Corp Class A Ordinary Shares
CMCA
| $373K | 0.01% |
+36,898
| New | +$371K |
|
609
Knowles
KN
$3.36B
| $372K | 0.01% |
+30,566
| New | +$490K |
|
610
Axcelis
ACLS
$4.2B
| $359K | 0.01% |
5,934
-2,832
| -32% | -$183K |
|
611
Duolingo
DUOL
$5.71B
| $357K | 0.01% |
+3,749
| New | +$365K |
|
|
HLVX
612
DELISTED
HilleVax
HLVX
| $344K | ﹤0.01% |
+20,108
| New | +$292K |
|
613
Sphere Entertainment
SPHR
$5.54B
| $339K | ﹤0.01% |
+7,683
| New | +$431K |
|
614
PC Connection
CNXN
$2.19B
| $324K | ﹤0.01% |
+7,181
| New | +$339K |
|
|
APCA
615
DELISTED
AP Acquisition Corp
APCA
| $304K | ﹤0.01% |
30,000
| – | – |
|
616
Carvana
CVNA
$75.1B
| $301K | ﹤0.01% |
+74,035
| New | +$483K |
|
617
Qualys
QLYS
$6.29B
| $297K | ﹤0.01% |
2,131
-3,268
| -61% | -$461K |
|
618
Tevogen Inc. Common Stock
TVGN
$27.3M
| $296K | ﹤0.01% |
585
+85
| +17% | +$42.9K |
|
|
KRON
619
DELISTED
Kronos Bio
KRON
| $295K | ﹤0.01% |
87,934
-251,439
| -74% | -$1.13M |
|
620
Ubiquiti
UI
$34.3B
| $294K | ﹤0.01% |
+1,000
| New | +$295K |
|
|
SAGA
621
DELISTED
Sagaliam Acquisition Corp. Class A Common Stock
SAGA
| $288K | ﹤0.01% |
+28,800
| New | +$287K |
|
|
DCT
622
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $286K | ﹤0.01% |
+24,129
| New | +$319K |
|
623
PAR Technology
PAR
$706M
| $280K | ﹤0.01% |
+9,477
| New | +$352K |
|
|
NUVL
624
DELISTED
Nuvalent
NUVL
| $271K | ﹤0.01% |
+13,918
| New | +$233K |
|
625
AMC Global Media
AMCX
$490M
| $269K | ﹤0.01% |
+13,274
| New | +$366K |
|
Similar funds
TCIIS
UIM
VAI
KK
Woodline Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Woodline Partners held 983 positions worth $7.16B, up 10% from $6.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Woodline Partners deployed $831M of net new capital in Q3 2022, opening 189 new positions and adding to 207 existing holdings. Its largest new stake was Amazon: 683,398 shares worth $77.2M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $73.2M trimmed.
- Woodline Partners's largest Q3 2022 buy was Amazon: 683,398 shares worth $77.2M.
- Woodline Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022, an estimated $146M increase.
- Woodline Partners's biggest Q3 2022 reduction was Eli Lilly, cutting an estimated $73.2M.
- Woodline Partners fully exited Palo Alto Networks in Q3 2022, selling an estimated $59.8M.
- Woodline Partners's ten largest holdings make up 17% of its $7.16B portfolio in Q3 2022.
- Woodline Partners opened 189 new positions and closed 240 in Q3 2022.
- Woodline Partners's portfolio value rose 10% quarter-over-quarter to $7.16B.
Based on Woodline Partners's 13F filing for Q3 2022, filed 14 Nov 2022.